Literature DB >> 15712069

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required.

Stéphane Vigouroux1, Odile Morin, Philippe Moreau, Françoise Méchinaud, Nadine Morineau, Béatrice Mahé, Patrice Chevallier, Thierry Guillaume, Viviane Dubruille, Jean-Luc Harousseau, Noël Milpied.   

Abstract

We describe 4 cases of zygomycosis that occurred after prolonged use of voriconazole in severely immunocompromised patients with hematologic disease. An invasive infection was present in 3 patients who died soon after the diagnosis at 12, 13, and 45 days. Physicians should be mindful of this potential risk after treatment with voriconazole.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15712069     DOI： 10.1086/427752

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  32 in total

Review 1.  Sudden death in a patient with bone marrow transplant by a fungus among us.

Authors:  Lemuel Non; Joanna Paula Sta Cruz; Sherilyn Tuazon
Journal:  BMJ Case Rep       Date:  2014-11-12

2.  Mucormycosis in Mato Grosso, Brazil: a case reports, caused by Rhizopus microsporus var. oligosporus and Rhizopus microsporus var. rhizopodiformis.

Authors:  Luciano Corrêa Ribeiro; Bodo Wanke; Manuela da Silva; Luciana Basili Dias; Renato Mello; Fernando Artur Pena Borges Canavarros; Diniz Pereira Leite; Rosane Christine Hahn
Journal:  Mycopathologia       Date:  2011-09-28       Impact factor: 2.574

3.  Rhinocerebral mucormycosis--a case report.

Authors:  Shaji Thomas; V Dal Singh; Yuvaraj Vaithilingam; Sumeeth Cyriac Thayil; Rohit Kothari
Journal:  Oral Maxillofac Surg       Date:  2011-09-28

4.  In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Teresa Peláez; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

5.  Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.

Authors:  Teclegiorgis Gebremariam; Sondus Alkhazraji; Clara Baldin; Laura Kovanda; Nathan P Wiederhold; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

6.  Impact of zygomycosis on microbiology workload: a survey study in Spain.

Authors:  Marta Torres-Narbona; Jesús Guinea; José Martínez-Alarcón; Patricia Muñoz; Ignacio Gadea; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

7.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

8.  Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.

Authors:  Corrado Girmenia; Maria Luisa Moleti; Alessandra Micozzi; Anna Paola Iori; Walter Barberi; Robin Foà; Pietro Martino
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Zygomycosis: an emerging fungal infection with new options for management.

Authors:  Carol A Kauffman; Anurag N Malani
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

10.  Emerging invasive fungal diseases in transplantation.

Authors:  Perrine Parize; Blandine Rammaert; Olivier Lortholary
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.